ITTO950112A0 - Composizione e procedimemto per prevenire e trattare infiammazioni conimmunoglobina a. - Google Patents

Composizione e procedimemto per prevenire e trattare infiammazioni conimmunoglobina a.

Info

Publication number
ITTO950112A0
ITTO950112A0 ITTO950112A ITTO950112A ITTO950112A0 IT TO950112 A0 ITTO950112 A0 IT TO950112A0 IT TO950112 A ITTO950112 A IT TO950112A IT TO950112 A ITTO950112 A IT TO950112A IT TO950112 A0 ITTO950112 A0 IT TO950112A0
Authority
IT
Italy
Prior art keywords
immunoglobin
procedure
composition
prevent
treat inflammation
Prior art date
Application number
ITTO950112A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22731867&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITTO950112(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of ITTO950112A0 publication Critical patent/ITTO950112A0/it
Publication of ITTO950112A1 publication Critical patent/ITTO950112A1/it
Application granted granted Critical
Publication of IT1281188B1 publication Critical patent/IT1281188B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT95TO000112A 1994-02-18 1995-02-17 Composizione per prevenire e trattare infiammazioni con immunoglobulina a. IT1281188B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19806794A 1994-02-18 1994-02-18

Publications (3)

Publication Number Publication Date
ITTO950112A0 true ITTO950112A0 (it) 1995-02-17
ITTO950112A1 ITTO950112A1 (it) 1996-08-17
IT1281188B1 IT1281188B1 (it) 1998-02-17

Family

ID=22731867

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95TO000112A IT1281188B1 (it) 1994-02-18 1995-02-17 Composizione per prevenire e trattare infiammazioni con immunoglobulina a.

Country Status (12)

Country Link
US (1) US5833984A (it)
EP (1) EP0744957B1 (it)
JP (1) JPH09509164A (it)
AT (2) ATE182793T1 (it)
AU (1) AU1809495A (it)
CA (1) CA2183566A1 (it)
DE (2) DE19505287A1 (it)
DK (1) DK0744957T3 (it)
ES (1) ES2135703T3 (it)
GR (1) GR3031691T3 (it)
IT (1) IT1281188B1 (it)
WO (1) WO1995022350A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114894911A (zh) * 2022-03-18 2022-08-12 辽宁成大生物股份有限公司 一种控制牛血清产品质量方法

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
DE19600939C1 (de) * 1996-01-12 1997-08-28 Immuno Ag Verfahren zur Trennung von IgG und IgA
US6344545B1 (en) * 1996-06-14 2002-02-05 Progenics Pharmaceuticals, Inc. Method for preventing HIV-1 infection of CD4+ cells
EP0839915A1 (en) * 1996-11-01 1998-05-06 Institut Suisse De Recherches Experimentales Sur Le Cancer Isrec Secretory immunoglobulin A as a mucosal vaccine delivery system
US20020114802A1 (en) * 1998-02-10 2002-08-22 Tjellstrom Bo Arthur Einar Oral immunoglobulin treatment for inflammatory bowel disease
JP2002542205A (ja) * 1999-04-19 2002-12-10 リチャード ワイスバート、 貯蔵ヒト免疫グロブリンおよび制酸剤の経口投与による成人リウマチ様関節炎の処置
US20020098182A1 (en) * 2000-09-28 2002-07-25 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
EP1341552A2 (en) * 2000-09-28 2003-09-10 Research Corporation Technologies, Inc Treatment of immune-mediated diseases by oral administration of plasma fractions
EP1355665A2 (en) * 2000-10-06 2003-10-29 Richard Weisbart Treatment of juvenile rheumatioid arthritis by oral administration of pooled human immunoglobulin and an antacid
US20040180045A1 (en) * 2001-09-28 2004-09-16 Richard Weisbart Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US20060057223A1 (en) * 2004-09-10 2006-03-16 Dimauro Thomas M Intradiscal production of autologous interleukin antagonist
WO2009065093A2 (en) * 2007-11-17 2009-05-22 University Of Medicine And Dentistry Of New Jersey Use of stem cells for wound healing
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
US20090162351A1 (en) * 2007-12-21 2009-06-25 Depuy Spine, Inc. Transdiscal administration of inhibitors of p38 MAP kinase
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837285B2 (ja) * 1975-05-29 1983-08-15 カブシキガイシヤ ミドリジユウジ チヨウナイカンセンシヨウチリヨウザイノセイゾウホウホウ
JPS5653622A (en) * 1979-10-09 1981-05-13 Mochida Pharmaceut Co Ltd Preventive and remedy for infectious disease of respiratory organ and oral cavity
JPS5759815A (en) * 1980-09-30 1982-04-10 Mochida Pharmaceut Co Ltd Drug composition having preventing and remedying action on rotavirus infectious disease
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
AT402789B (de) * 1991-03-25 1997-08-25 Immuno Ag Pharmazeutische präparation auf basis von plasmaproteinen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114894911A (zh) * 2022-03-18 2022-08-12 辽宁成大生物股份有限公司 一种控制牛血清产品质量方法

Also Published As

Publication number Publication date
EP0744957A1 (en) 1996-12-04
EP0744957B1 (en) 1999-08-04
IT1281188B1 (it) 1998-02-17
JPH09509164A (ja) 1997-09-16
DE69511245T2 (de) 1999-12-16
DK0744957T3 (da) 2000-03-06
CA2183566A1 (en) 1995-08-24
ITTO950112A1 (it) 1996-08-17
US5833984A (en) 1998-11-10
ATE182793T1 (de) 1999-08-15
AU1809495A (en) 1995-09-04
AT402790B (de) 1997-08-25
GR3031691T3 (en) 2000-02-29
ES2135703T3 (es) 1999-11-01
ATA29495A (de) 1997-01-15
DE19505287A1 (de) 1995-08-24
WO1995022350A1 (en) 1995-08-24
DE69511245D1 (de) 1999-09-09

Similar Documents

Publication Publication Date Title
ITTO950112A0 (it) Composizione e procedimemto per prevenire e trattare infiammazioni conimmunoglobina a.
DE69412344D1 (de) Kraftstoffezusammensetzung
FI953499L (fi) Polttoainekoostumus
FI951629A7 (fi) Sellulaasimuunnokset
DE69413969D1 (de) Hautpflegezusammensetzung mit emulsioniertem petroleum
FI960105A7 (fi) Lasikuitukoostumus
FI961720A0 (fi) Uusi koostumus
FI972433A7 (fi) Rantes-peptidi ja fragmentteja sekä tätä sisältäviä tulehduksen hoitoo n soveltuvia koostumuksia
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
BR9502407A (pt) Composição lubrificante e concetrado
FI971750A7 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
ZA94404B (en) 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
DE59507901D1 (de) Einspritzdüse
BR9510062A (pt) Macromonômeto esterificado e composição
BR9509688A (pt) Composto e composição farmacêutica
DE59502382D1 (de) Einspritzventil
DE69434783D1 (de) Mitteldestillate-Brennstoffzusammensetzung
DE69529904D1 (de) Dampfungsglied
DE69411083D1 (de) Kraftstoffzusammensetzung
FI944376L (fi) Menetelmä ja sovitelma muuton pysäyttämiseksi
FI953615L (fi) Haavanparannuskoostumus
FI964446L (fi) Uusia tetrapeptidejä, niiden valmistus ja käyttö
EP0590403A3 (en) Compositions having analgesic action.
DE69503641D1 (de) Sulfatagglomeration
DE59507933D1 (de) Endoskopisch einsetzbare Elektrodenanordnung

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990226